Show simple item record

dc.creatorGarcía-Labastida,Laura
dc.creatorGarza-Guajardo,Raquel
dc.creatorBarboza-Quintana,Oralia
dc.creatorRodríguez-Sanchez,Irám Pablo
dc.creatorAncer-Rodríguez,Jesús
dc.creatorFlores-Gutierrez,Juan Pablo
dc.creatorGómez-Macías,Gabriela Sofía
dc.date2014-01-01
dc.date.accessioned2019-05-02T21:22:19Z
dc.date.available2019-05-02T21:22:19Z
dc.identifierhttps://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0716-97602014000100043
dc.identifier.urihttp://revistaschilenas.uchile.cl/handle/2250/82403
dc.descriptionBACKGROUND: Pure mucinous adenocarcinoma of the breast is a rare entity characterized by the production of variable amounts of mucin comprising 1% to 6% of breast carcinomas. Some mucinous adenocarcinomas have shown expression of intestinal differentiation markers such as MUC-2. This study examines the expression of intestinal differentiation markers in this type of breast carcinoma. RESULTS: Twenty-two cases of pure mucinous adenocarcinoma of the breast were assessed. Immunochemistry was performed for beta-catenin, CDX-2 and MUC-2. All cases were positive for B-catenin. MUC-2 positivity was observed in all cases; 63. 6% were 3 plus positive. All cases were negative for CDX-2. CONCLUSIONS: These results suggest that mucinous breast carcinomas express some markers of intestinal differentiation, such as MUC-2 and beta-catenin; however, future studies with a larger series of cases and using molecular techniques that help affirm these results are needed.
dc.formattext/html
dc.languageen
dc.publisherSociedad de Biología de Chile
dc.relation10.1186/0717-6287-47-43
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourceBiological Research v.47 2014
dc.subjectBreast mucinous carcinoma
dc.subjectInmunohistochemical
dc.subjectIntestinal differentiation
dc.titleCDX-2, MUC-2 and B-catenin as intestinal markers in pure mucinous carcinoma of the breast


This item appears in the following Collection(s)

Show simple item record